Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Articles
Articles
Do End-of-Life Products Deserve Special Treatment?
End-of-Life Care
,
ISPOR Annual Meeting
,
Policies & Guidelines
July/August 2010, Vol 1, No 3
Read More
Individualizing Colorectal Cancer Care through Genetics
Annual ONS Congress
,
Colorectal Cancer
,
Personalized Medicine
July/August 2010, Vol 1, No 3
Read More
CER “Cyberinfrastructure” May Boost Cancer Research
Comparative Effectiveness
June 2010, Vol 1, No 2
Researchers from the University of California and the University of California San Diego (UCSD) have begun working on a prototype “cyberinfrastructure” that would allow cancer researchers to collect and interpret data from multiple sources to compare the effectiveness of preventive measures, drugs, treatments, and interventions during the course of clinical trials.
Read More
Oncology-related Updates from the US Food and Drug Administration
FDA Approvals, News & Updates
June 2010, Vol 1, No 2
Read More
Cervical Cancer Screening Only Marginally Improved
By
Rosemary Frei, MSc
Genetic Testing
,
In the Literature
,
Personalized Medicine
June 2010, Vol 1, No 2
A new study suggests that removing financial incentives for screening for cervical cancer, diabetic retinopathy, and hypertension and diabetes control reduces performance, including screening rates. The study was published online in May in the
British Medical Journal
(2010;340:c1898).
Read More
Premarket Policies May Generate the Best Value
By
Jayson Slotnik, JD, MPH
Value-Based Care
,
VBCC Perspectives
June 2010, Vol 1, No 2
The Patient Protection and Affordable Care Act (PPACA), which is Congress’ latest attempt to reform our healthcare system, creates 3 new entities that will test new payment methodologies or compare current treatments in an attempt to determine better value for our healthcare dollar.
Read More
Keep a Close Eye on Heart and Liver Transplant Patients
2nd European Lung Cancer Conference
June 2010, Vol 1, No 2
Read More
Accelerated Radiotherapy Brings Survival Benefit
2nd European Lung Cancer Conference
June 2010, Vol 1, No 2
Geneva—Giving lung cancer patients radiotherapy more frequently and over a shorter period of time provides an overall survival benefit, according to the results of a meta-analysis presented at the 2nd European Lung Cancer Conference.
Read More
Radiation with Pemetrexed a Possibility
2nd European Lung Cancer Conference
June 2010, Vol 1, No 2
Geneva—Combining high-dose pemetrexed (Alimta, Eli Lilly) with concurrent radiation for lung cancer is feasible, according to results of a phase 1 study presented at the 2nd European Lung Cancer Conference. Administering pemetrexed at high doses with radiation may increase the effectiveness of treatment.
Read More
An Early Look at New Drugs on the Horizon
AMCP Annual Meeting
June 2010, Vol 1, No 2
Washington, DC—A first look at new cancer therapies was the focus of the 6th annual New Drugs on the Horizon symposium held as a special session at the American Association for Cancer Research (AACR) annual meeting.
Read More
Page 325 of 330
322
323
324
325
326
327
328
Top Trending Articles
1.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
2.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
3.
Financial Toxicity in Cancer Care: Why the Conversation Must Start Before Treatment Begins
Jan Hailey, MHL, CMC, CMCO, CMIS, CMOM, CMCA-E/M
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma